The role of basic fibroblast growth factor in oral submucous fibrosis pathogenesis

Journal of Oral Pathology and Medicine

Volumn 37, Issue 7, 2008, Pages 402-411

  Bishen, Kundendu Arya ^a   Radhakrishnan, Raghu ^a   Satyamoorthy, Kapaettu ^b  

^a MANIPAL COLLEGE OF DENTAL SCIENCES   (India)

^b MANIPAL COLLEGE OF MEDICAL SCIENCES   (Nepal)

Author keywords

Bfgf; Cytokines; Growth factors; IHC; OSF

Indexed keywords

FIBROBLAST GROWTH FACTOR; FUCHSINE; FIBROBLAST GROWTH FACTOR 2;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; ENDOTHELIUM CELL; FEMALE; FIBROBLAST; FIBROSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MOUTH DISEASE; PRIORITY JOURNAL; CASE CONTROL STUDY; EXTRACELLULAR MATRIX; HOSPITALIZATION; METABOLISM; MIDDLE AGED; PATHOLOGY; REFERENCE VALUE; TISSUE DISTRIBUTION;

ADULT; CASE-CONTROL STUDIES; ENDOTHELIAL CELLS; EXTRACELLULAR MATRIX; FEMALE; FIBROBLAST GROWTH FACTOR 2; FIBROBLASTS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; ORAL SUBMUCOUS FIBROSIS; REFERENCE VALUES; SEVERITY OF ILLNESS INDEX; TISSUE DISTRIBUTION;

EID: 55249085661     PISSN: 09042512     EISSN: 16000714     Source Type: Journal    
DOI: 10.1111/j.1600-0714.2008.00649.x     Document Type: Article

References (33)

1. Ahuja SS, Agrawal GD. Submucous fibrosis of Oral mucosa. J Oral Med 1971; 26: 35-6.
2. Hardie J. Oral submucous fibrosis. A review with case reports. J Can Dent Assoc 1987; 53: 389-93.
3. Sirsat SM, Pindborg JJ. Sub epithelial changes in oral submucous fibrosis. Acta Pathol Microbiol Scand 1967; 70: 161-73.
4. Clarke MS, Khakee R, McNeil PL. Loss of cytoplasmic basic fibroblast growth factor from physiologically wounded myofibers of normal and dystrophic muscle. J Cell Sci 1993; 106: 121-33.
5. Gupta A, Bazer FW, Jaeger LA. Immunolocalization of acidic and basic fibroblast growth factors in porcine uterine and conceptus tissues. Biol Reprod 1997; 56: 1527-36.
6. Yoshimura K, Dissanayake U, Nanayakkara D, Kagey-ama I, Kobayashi K. Morphological changes in oral mucosae and their connective tissue cores regarding oral submucous fibrosis. Arch Histol Cytol 2005; 68: 185-92.
7. Haque MF, Harris M, Meghji S, Barrett AW. Immunolocalization of cytokines and growth factors in oral submucous fibrosis. Cytokine 1998; 10: 713-9.
8. Zhang K, Phan SH. Cytokines and pulmonary fibrosis. Biol Signals 1996; 5: 232-9.
9. Galzie Z, Kinsella AR, Smith JA. Fibroblast growth factors and their receptors. Biochem Cell Biol 1997; 75: 669-85.
10. Deuel TF. Polypeptide growth factors: roles in normal and abnormal cell growth. Annu Rev Cell Biol 1987; 3: 443-92.
11. Weston CA, Weeks BS. bFGF stimulates U937 cell adhesion to fibronectin and secretion of gelatinase B. Biochem Biophys Res Commun 1996; 228: 318-23.
12. Knerer B, Formanek M, Temmel A, Martinek H, Schickinger B, Kornfehl J. The role of fibroblasts from oropharyngeal mucosa in producing proinflammatory and mitogenic cytokines without prior stimulation. Eur Arch Otorhinolaryngol 1999; 256: 266-70.
13. Takehara K, Soma Y, Igarashi A, Kikuchi K, Moro A, Ishibashi Y. Response of scleroderma fibroblasts to various growth factors. Arch Dermatol Res 1991; 283: 461-4.
14. Zittermann SI, Issekutz AC. Basic fibroblast growth factor (bFGF, FGF-2) potentiates leukocyte recruitment to inflammation by enhancing endothelial adhesion molecule expression. Am J Pathol 2006; 168: 835-46.
15. Xu C, Peng X, Liu S, Fang C. Quantitative and immu-nohistochemical analysis of endothelin-1 in oral submucous fibrosis. Hua Xi Kou Qiang Yi Xue Za Zhi 2000; 18: 394-6.
16. Tsai CH, Yang SF, Chen YJ, Chou MY, Chang YC. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro. J Oral Pathol Med 2005; 34: 100-5.
17. Fang CY, Han WN, Fong DY. A morphometric study on the microvessel in oral submucous fibrosis. Hunan Yi Ke Da Xue Xue Bao 2000; 25: 55-7.
18. Salcedo R, Wasserman K, Young HA, et al. Vascular endothelial growth factor and basic fibroblast growth factor induce expression of CXCR4 on human endothelial cells: in vivo neovascularization induced by stromal-derived factor-1alpha. Am J Pathol 1999; 154: 1125-35.
19. Wojas-Pelc A, Lipko-Godlewska S. Pathogenesis of skin scleroderma - literature review. Przegl Lek 2005; 62: 310-3.
20. Denton CP, Xu S, Black CM, Pearson JD. Scleroderma fibroblasts show increased responsiveness to endothelial cell-derived IL-1 and bFGF. J Invest Dermatol 1997; 108: 269-74.
21. Qu Z, Liebler JM, Powers MR, et al. Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 1995; 147: 564-73.
22. Morita H, Shinzato T, David G, Mizutani A, et al. Basic fibroblastic growth factor binding domain of heparin sulphate in the human glomerulosclerosis and renal tubulointerstetial fibrosis. Lab Invest 1994; 71: 528-35.
23. Thomas G, Clayton A, Thomas J, Davies M, Steadman R. Structural and functional changes in heparan sulfate proteoglycan expression associated with the myofibrob-lastic phenotype. Am J Pathol 2003; 162: 977-89.
24. Yoon SY, Tefferi A, Li CY. Bone marrow stromal cell distribution of basic fibroblast growth factor in chronic myeloid disorders. Haematologica 2001; 86: 52-7.
25. Chen QS, Wang ZY, Han ZC. Enhanced growth of megakaryocyte colonies in culture in the presence of heparin and fibroblast growth factor. Int J Hematol 1999; 70: 155-62.
26. Van Wyk CW, Seedat HA, Philips VM. Collagen in submucous fibrosis: an electron-microscopic study. J Oral Pathol Med 1990; 19: 182-87.
27. Reichart P, Boning W, Srisuwan S, et al. Ultrastructural findings in the oral mucosa of betel chewers. J Oral Pathol 1984; 13: 166-77.
28. Eddy AA. Molecular basis of renal fibrosis. Pediatr Nephrol 2000; 15: 290-301.
29. Shieh DH, Chiang LC, Shieh TY. Augmented mRNA expression of tissue inhibitor of metalloproteinase-1 in buccal mucosal fibroblasts by arecoline and safrole as a possible pathogenesis for oral submucous fibrosis. Oral Oncol 2003; 39: 728-35.
30. Gomez DE, Alonso DF, Yoshiji H, Torgeirsson UP. Tissue inhibitors of metalloproteinases: structure, regulation and biological function. Eur J Cell Biol 1997; 74: 111-22.
31. Yang SF, Hsieh YS, Tsai CH, Chou MY, Chang YC. The upregulation of type I plasminogen activator inhibitor in oral submucous fibrosis. Oral Oncol 2003; 39: 367-72.
32. Silverio-Ruiz KG, Martinez AE, Garlet GP, et al. Opposite effects of bFGF and TGF-beta on collagen metabo- lism by human periodontal ligament fibroblasts. Cytokine 2007; 39: 130-7.
33. Detamore MS, Athanasiou KA. Effects of growth factors on temporomandibular joint disc cells. Arch Oral Biol 2004; 49: 577-83.